Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q4 2020 Earnings Conference Call February 11, 2021 5:00 PM ET Company Participants Joshua Higa - Director, Investor Relations Emil Kakkis - Chief Executive Officer and President Camille Bedrosian - Chief Medical Officer Erik Harris - Chief Commercial Officer Mardi Dier - Chief Financial Officer Conference Call Participants Yaron Werber - Cowen Gena Wang - Barclays Cory Kasimov - JPMorgan Joon Lee - Truist Securities Yigal Nochomovitz - Citigroup Liisa Bayko - Eve ...

January 2021 Corporate Deck Legal Warning Cautionary note regarding forward-looking statements: This presentation contains forward-looking statements, including, but not limited to, statements regarding our expectations and projections regarding our future operating results and financial performance, anticipated cost or expense reductions, plans with respect to commercializing our product and product candidates, our translational research program, expectations regarding our manufacturing capabilities, the e ...

November 2020 Corporate Presentation Legal Warning Cautionary note regarding forward-looking statements: This presentation contains forward-looking statements, including, but not limited to, statements regarding our expectations and projections regarding our future operating results and financial performance, anticipated cost or expense reductions, plans with respect to commercializing our product and product candidates, our translational research program, expectations regarding our manufacturing capabiliti ...